Achieve Life Sciences, Inc.

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation aids in the United States and internationally. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. Show More...

  • Website http://www.achievelifesciences.com
  • Sector Healthcare
  • Industry Biotechnology
  • Last Quote 3.58 USD
  • Last Updated 30-05-2025
  • External Links Yahoo Finance Morningstar Ratios
  •   2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM
    Earnings Per Share USD -196.9 -166.1 -171.6 -238.7 -159.5 -70.4 -581.25 -22.07 -3.61 -1.99 -1.22
    Dividends USD
    Payout Ratio % *
    Shares Mil 4.0 8.0 14.0
    Book Value Per Share * USD 500.72 451.58 496.89 325.66 188.92 143.06 89.46 8.94 2.11 0.28 0.4
    Free Cash Flow Per Share * USD -420.98 -226.79 -356.16 -287.11 -120.8 -25.88 -123.22 -77.37 -5.03 -2.15
    Return on Assets % -15.84 -18.58 -28.13 -46.26 -46.87 -29.35 -46.99 -56.65 -87.57 -81.64 -88.68
    Financial Leverage (Average) 2.04 2.2 1.24 1.5 1.65 1.55 1.45 1.26 1.21 1.17 1.11
    Return on Equity % -37.52 -39.12 -43.46 -61.59 -73.64 -47.0 -71.37 -78.85 -107.15 -96.86 -109.72
    Return on Invested Capital % -31.58 -32.81 -38.83 -56.44 -69.0 -47.06 -71.76 -78.72 -108.31 -96.77 -107.45
    Interest Coverage
    Current Ratio 3.25 2.19 6.94 3.61 2.51 2.77 3.18 2.93 4.75 6.04 8.36
    Quick Ratio 3.14 2.14 6.61 3.22 2.38 2.68 3.07 2.63 4.47 5.81 7.87
    Debt/Equity 0.15 0.21 0.06 0.1 0.010 0.010